Literature DB >> 20589421

Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus.

Li Long1, Yanying Liu, Shiyao Wang, Yi Zhao, Jianping Guo, Ping Yu, Zhanguo Li.   

Abstract

OBJECTIVE: This study aims to explore the potential role of circulating Dickkopf-1 (Dkk-1) and osteoprotegerin (OPG) in evaluating erosive arthritis in systemic lupus erythematosus (SLE).
METHODS: Serum Dkk-1 and OPG levels were examined in 130 SLE patients including eight with erosive arthritis, 100 rheumatoid arthritis (RA) patients and 50 healthy individuals by ELISA. Comparison of serum Dkk-1 levels with presence of anti-cyclic citrullinated peptides (CCP) antibodies in evaluating erosive arthritis in SLE was carried out. Associations of Dkk-1 and OPG levels with results of clinical examination were also noted.
RESULTS: Dkk-1 levels were significantly increased in eight SLE patients with erosive arthritis, compared to 58 SLE patients with non-erosive arthritis, 64 SLE patients without arthritis, and healthy controls, while similar with RA. In contrast, no significant changes of OPG levels were found except for higher levels in RA. No differences were found in Dkk-1 levels of SLE patients with erosive arthritis subdivided according to presence or absence of anti-CCP antibodies. Moreover, higher levels of Dkk-1 were identified in anti-CCP positive SLE patients with erosive arthritis compared to those with non-erosive arthritis or without arthritis. However, no significant correlations between Dkk-1 and OPG levels or between Dkk-1 levels and other laboratory and clinical manifestations were observed.
CONCLUSIONS: High levels of circulating Dkk-1 were associated with bone erosion in patients with SLE, even when anti-CCP antibodies were absent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20589421     DOI: 10.1007/s10875-010-9436-z

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

1.  Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus.

Authors:  I E A Hoffman; I Peene; L Cebecauer; D Isenberg; T W J Huizinga; A Union; L Meheus; K De Bosschere; F Hulstaert; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

2.  sRANKL and OPG in serum and synovial fluid of patients with rheumatoid arthritis in comparison to non-destructive chronic arthritis.

Authors:  Gert E Hein; Marit Meister; Peter Oelzner; Sybille Franke
Journal:  Rheumatol Int       Date:  2008-01-03       Impact factor: 2.631

3.  Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?

Authors:  P Spelling; E Bonfá; V F Caparbo; R M R Pereira
Journal:  Scand J Rheumatol       Date:  2008 Nov-Dec       Impact factor: 3.641

4.  Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand.

Authors:  Lumelle A Schneeweis; Derril Willard; Marcos E Milla
Journal:  J Biol Chem       Date:  2005-10-07       Impact factor: 5.157

5.  Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.

Authors:  M Skoumal; G Kolarz; G Haberhauer; W Woloszczuk; G Hawa; A Klingler
Journal:  Rheumatol Int       Date:  2005-05-12       Impact factor: 2.631

6.  Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  R Mediwake; D A Isenberg; G A Schellekens; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

7.  Lupus arthropathy: a case series of patients with rhupus.

Authors:  Andrés Fernández; Gerardo Quintana; Federico Rondón; José Félix Restrepo; Alvaro Sánchez; Eric L Matteson; Antonio Iglesias
Journal:  Clin Rheumatol       Date:  2005-06-25       Impact factor: 2.980

8.  Lupus arthropathy: historical evolution from deforming arthritis to rhupus.

Authors:  Andrés Fernández; Gerardo Quintana; Eric L Matteson; José Félix Restrepo; Federico Rondón; Alvaro Sánchez; Antonio Iglesias
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

9.  Clinical and immunogenetic characterization of Mexican patients with 'rhupus'.

Authors:  J A Simón; J Granados; J Cabiedes; J Ruíz Morales; J Alcocer Varela
Journal:  Lupus       Date:  2002       Impact factor: 2.911

Review 10.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

View more
  7 in total

1.  Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients.

Authors:  L P C Seguro; C B Casella; V F Caparbo; R M Oliveira; A Bonfa; E Bonfa; R M R Pereira
Journal:  Osteoporos Int       Date:  2014-08-22       Impact factor: 4.507

Review 2.  Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Peng Wang; Si Li; Li-Na Liu; Tian-Tian Lv; Xiao-Mei Li; Xiang-Pei Li; Hai-Feng Pan
Journal:  Clin Rheumatol       Date:  2017-07-11       Impact factor: 2.980

Review 3.  Paget's disease of bone: an osteoimmunological disorder?

Authors:  Mohamed S Numan; Nathalie Amiable; Jacques P Brown; Laëtitia Michou
Journal:  Drug Des Devel Ther       Date:  2015-08-14       Impact factor: 4.162

4.  Serum DKK-1 level in the development of ankylosing spondylitis and rheumatic arthritis: a meta-analysis.

Authors:  Li Zhang; Hui Ouyang; Zhen Xie; Zhi-Hui Liang; Xiong-Wen Wu
Journal:  Exp Mol Med       Date:  2016-04-22       Impact factor: 8.718

5.  Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis.

Authors:  Jing Xue; Jiali Yang; Lijuan Yang; Shaolan Zhou; Chen Ji; Xuemei Wang; Nan Yu; Xiaoming Liu; Shuhong Chi
Journal:  J Immunol Res       Date:  2017-03-08       Impact factor: 4.818

Review 6.  The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders.

Authors:  Eugenia Bertoldo; Giovanni Adami; Maurizio Rossini; Alessandro Giollo; Giovanni Orsolini; Ombretta Viapiana; Davide Gatti; Angelo Fassio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-21       Impact factor: 5.555

Review 7.  Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases.

Authors:  Juan Shi; Shuhong Chi; Jing Xue; Jiali Yang; Feng Li; Xiaoming Liu
Journal:  J Immunol Res       Date:  2016-03-27       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.